What if you could streamline and accelerate your early phase development while maximizing flexibility, time and cost, so you can get the data you need faster?
Dr Rebecca Coutts
Rebecca discusses the development of an oncology product utilizing XcelodoseTM microdosing technology.
Brendan talks about how Speed to Study is used to help streamline early phase development in clinical trials.
Brendan shares a Speed to StudyTM case study of oral solid dose capsule filling for early liver disease treatment.
Katty shares an example of how Speed to StudyTM helped expedite IMP study materials, to analize their impact on seasonal allergies.
The PCI WayTM - swiftly initiating early phase trials to establish proof of concept, efficacy, and stability of your drug candidates quickly and efficiently
“Accelerate your drug to proof of concept with PCI’s Speed to StudyTM services.”
Executive Director, Operations
"Companies that take steps to identify potential problems in advance and then proactively stop the development of an imperiled trial have a much higher likelihood of ultimately reaching the market with their drugs.”